Back to TSHA
Vestal Point Capital, LP → TSHA
Vestal Point Capital, LP TSHA Position History
Taysha Gene Therapies, Inc. • Healthcare
Quarters held
4
Latest value
$87.9M
Q3 2026
Peak value
$132.2M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $75.6M |
| Q1 2026 | $80.5M |
| Q2 2026 | $132.2M |
| Q3 2026 | $87.9M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $87.9M | 18.05M | — | — |
| Q2 2026 | $132.2M | 19.41M | — | — |
| Q1 2026 | $80.5M | 18.00M | — | — |
| Q4 2025 | $75.6M | 13.75M | — | — |